Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea · Delayed Price · Currency is KRW 4,030.00
+85.00 (2.15%)
At close: Aug 24, 2026
Jin Yang Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 50,931 | 64,938 | 66,504 | 66,805 | 70,257 | 78,689 | |
Market Cap Growth | -26.53% | -2.35% | -0.45% | -4.91% | -10.72% | 0.57% |
Enterprise Value | 119,681 | 137,575 | 148,150 | 73,349 | 78,626 | 79,706 |
Last Close Price | 3945.00 | 5030.00 | 5652.12 | 5859.13 | 6021.93 | 6356.42 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 2.23 | 2.91 | 2.24 | 5.41 | 5.71 | 8.25 |
PS Ratio | 0.41 | 0.54 | 0.59 | 0.71 | 0.92 | 1.25 |
PB Ratio | 0.31 | 0.41 | 0.56 | 0.75 | 0.91 | 1.21 |
P/TBV Ratio | 0.33 | 0.42 | 0.58 | 0.80 | 0.95 | 1.24 |
P/FCF Ratio | 17.94 | - | - | 8.51 | 16.61 | - |
P/OCF Ratio | 4.74 | 44.33 | 5.20 | 7.83 | 9.43 | 39.93 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.96 | 1.14 | 1.31 | 0.78 | 1.03 | 1.27 |
EV/EBITDA Ratio | 18.85 | 27.88 | 10.79 | 6.47 | 5.86 | 8.74 |
EV/EBIT Ratio | 31.58 | 54.46 | 12.65 | 8.45 | 7.06 | 11.45 |
EV/FCF Ratio | 42.17 | - | - | 9.34 | 18.59 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.47 | 0.48 | 0.67 | 0.09 | 0.26 | 0.31 |
Debt / EBITDA Ratio | 11.98 | 15.55 | 5.80 | 0.69 | 1.49 | 2.20 |
Debt / FCF Ratio | 26.79 | - | - | 1.00 | 4.72 | - |
Net Debt / Equity Ratio | 0.42 | 0.44 | 0.65 | -0.01 | 0.12 | 0.08 |
Net Debt / EBITDA Ratio | 10.83 | 14.36 | 5.66 | -0.07 | 0.71 | 0.56 |
Net Debt / FCF Ratio | 24.22 | -25.30 | -1.00 | -0.10 | 2.24 | -9.41 |
Asset Turnover | 0.50 | 0.49 | 0.65 | 0.80 | 0.72 | 0.74 |
Inventory Turnover | 2.87 | 2.81 | 2.72 | 2.24 | 2.50 | 3.41 |
Quick Ratio | 0.35 | 0.33 | 1.44 | 1.24 | 0.98 | 1.16 |
Current Ratio | 0.52 | 0.52 | 2.19 | 1.96 | 1.50 | 1.51 |
Return on Equity (ROE) | 15.81% | 15.93% | 28.46% | 14.84% | 17.23% | 16.79% |
Return on Assets (ROA) | 0.94% | 0.64% | 4.21% | 4.63% | 6.54% | 5.12% |
Return on Invested Capital (ROIC) | 1.29% | 0.94% | 6.57% | 9.92% | 11.98% | 9.16% |
Return on Capital Employed (ROCE) | 2.10% | 1.40% | 5.60% | 9.10% | 13.30% | 9.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 44.77% | 34.32% | 44.65% | 18.47% | 17.52% | 12.12% |
FCF Yield | 5.57% | -4.31% | -116.19% | 11.75% | 6.02% | -0.69% |
Payout Ratio | 9.30% | 7.69% | 5.45% | 13.10% | 9.08% | 11.72% |
Buyback Yield / Dilution | - | -1.00% | 1.17% | 7.18% | -17.77% | -2.12% |